Clinical trials
Terminated trials in Moldova
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 3 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 9 |
| 2021 | 9 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 46 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 3 |
| Pfizer | 3 |
| Aligos Therapeutics | 2 |
| Antios Therapeutics, Inc | 2 |
| Invivyd, Inc. | 2 |
| Regeneron Pharmaceuticals | 2 |
| UCB Biopharma SRL | 2 |
| Alios Biopharma Inc. | 1 |
| ApcinteX Ltd | 1 |
| Arbutus Biopharma Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Crohn Disease | 6 |
| COVID-19 | 5 |
| Colitis, Ulcerative | 4 |
| Hepatitis B, Chronic | 4 |
| Arthritis, Rheumatoid | 3 |
| Hepatitis D | 2 |
| Inflammatory Bowel Diseases | 2 |
| Lupus Erythematosus, Systemic | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Multiple Sclerosis, Relapsing-Remitting | 2 |
Trials
Showing 26 to 46 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.